BRIMONIDINE Side Effects

6977431-9 | Conjunctivitis, Uveitis
on Aug 29, 2010 Male patient from UNITED STATES , 83 years of age, was diagnosed with open angle glaucoma and was treated with Brimonidine (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctivitis, uveitis. Brimonidine dosage: .

6736532-0 | Nephropathy Toxic, Renal Impairment
Patient was taking Brimonidine (View Usage). Patient had the following side effects: nephropathy toxic, renal impairment on May 10, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 88 years of age, weighting 143.3 lb, was diagnosed with glaucoma (What is glaucoma?), atrial fibrillation (What is atrial fibrillation?), anaemia, constipation (What is constipation?) and. Brimonidine dosage: . During the same period patient was treated with DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BIMATOPROST AND TIMOLOL MALEATE (View Bimatoprost And Timolol Maleate Review and Bimatoprost And Timolol Maleate Label ), NULYTELY (View Nulytely Review and Nulytely Label ).

6722061-7 | Nephropathy Toxic, Renal Impairment
Adverse event was reported on May 05, 2010 by a Male patient taking Brimonidine (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?), atrial fibrillation (What is atrial fibrillation?), anaemia, constipation (What is constipation?) and. Location: UNITED KINGDOM , 88 years of age, weighting 143.3 lb, After Brimonidine was administered, patient had the following side effects: nephropathy toxic, renal impairment. During the same period patient was treated with DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), GANFORT (BIMATOPROST, TIMOLOL) (View Ganfort (bimatoprost, Timolol) Review and Ganfort (bimatoprost, Timolol) Label ), NULYTELY (View Nulytely Review and Nulytely Label ).

6714305-2 | Nephropathy Toxic
on Apr 22, 2010 Male patient from UNITED KINGDOM , 88 years of age, weighting 143.3 lb, was diagnosed with glaucoma (What is glaucoma?), atrial fibrillation (What is atrial fibrillation?), anaemia, constipation (What is constipation?) and was treated with Brimonidine (View Usage). Patient experienced the following unwanted or unexpected effects: nephropathy toxic. Brimonidine dosage: . During the same period patient was treated with DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BIMATOPROST AND TIMOLOL MALEATE (View Bimatoprost And Timolol Maleate Review and Bimatoprost And Timolol Maleate Label ), MOVICOL (View Movicol Review and Movicol Label ).


6699221-7 | Nephropathy Toxic
on Apr 16, 2010 Male patient from UNITED KINGDOM , 88 years of age, weighting 143.3 lb, was diagnosed with glaucoma (What is glaucoma?), atrial fibrillation (What is atrial fibrillation?), anaemia, constipation (What is constipation?) and was treated with Brimonidine (View Usage). Patient had the following side effects: nephropathy toxic. Brimonidine dosage: . During the same period patient was treated with DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), GANFORT (BIMATOPROST, TIMOLOL) (View Ganfort (bimatoprost, Timolol) Review and Ganfort (bimatoprost, Timolol) Label ), MOVICOL (View Movicol Review and Movicol Label ).

6296408-2 | Asthma, Hypersensitivity
Patient was taking Brimonidine (View Usage). After Brimonidine was administered, patient had the following side effects: asthma (What is asthma?), hypersensitivity on Jul 23, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 56 years of age, was diagnosed with eye operation, eye inflammation and. Brimonidine dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PREDNISOLONE SODIUM PHOSPHATE (View Prednisolone Sodium Phosphate Review and Prednisolone Sodium Phosphate Label ), TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ). Patient was hospitalized.

5983117-X | Iris Convex, Maculopathy, Retinal Detachment, Retinal Disorder, Retinal Pigment Epitheliopathy
Adverse event was reported on Nov 24, 2008 by a Male patient taking Brimonidine (View Usage) (Dosage: ) was diagnosed with ocular hypertension and. Location: UNITED STATES , 49 years of age, Patient experienced the following unwanted or unexpected effects: iris convex, maculopathy, retinal detachment, retinal disorder (What is retinal disorder?), retinal pigment epitheliopathy. During the same period patient was treated with TIMOLOL (View Timolol Review and Timolol Label ), DORZOLAMIDE W/TIMOLOL (View Dorzolamide W/timolol Review and Dorzolamide W/timolol Label ), APRACLONIDINE (View Apraclonidine Review and Apraclonidine Label ), TRAVOPROST (View Travoprost Review and Travoprost Label ).